POU3F2 has been shown to be responsive to MAPK pathway activation and to modulate the levels of microphthalmia-associated transcription factor (MITF) so as to suppress the differentiated melanocytic phenotype and to enhance tumor metastasis (29). This evidence concerns the gene POU3F2 and neoplasm.